343 related articles for article (PubMed ID: 17299378)
21. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
[TBL] [Abstract][Full Text] [Related]
22. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
23. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
24. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
[TBL] [Abstract][Full Text] [Related]
25. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002.
Yang FY; Wahlqvist ML; Lee MS
Asia Pac J Clin Nutr; 2008; 17(2):339-51. PubMed ID: 18586657
[TBL] [Abstract][Full Text] [Related]
26. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
27. The metabolic syndrome among postmenopausal women in Ecuador.
Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
[TBL] [Abstract][Full Text] [Related]
28. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
[TBL] [Abstract][Full Text] [Related]
29. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
[TBL] [Abstract][Full Text] [Related]
30. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
31. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
32. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.
Hung J; McQuillan BM; Chapman CM; Thompson PL; Beilby JP
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1268-73. PubMed ID: 15790931
[TBL] [Abstract][Full Text] [Related]
33. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
Onat A; Ozhan H; Erbilen E; Albayrak S; Küçükdurmaz Z; Can G; Keleş I; Hergenç G
Int J Cardiol; 2009 Jun; 135(2):211-7. PubMed ID: 18582961
[TBL] [Abstract][Full Text] [Related]
34. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
Beddhu S; Kimmel PL; Ramkumar N; Cheung AK
Am J Kidney Dis; 2005 Oct; 46(4):577-86. PubMed ID: 16183411
[TBL] [Abstract][Full Text] [Related]
35. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
36. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.
Rosolova H; Petrlova B; Simon J; Sifalda P; Sipova I
Med Sci Monit; 2008 Aug; 14(8):CR411-5. PubMed ID: 18667998
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein B/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus.
Alfadda AA; Al-Daghri NM; Malabu UH
Saudi Med J; 2008 Jun; 29(6):821-5. PubMed ID: 18521458
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
39. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
[TBL] [Abstract][Full Text] [Related]
40. Comparisons between anthropometric indices for predicting the metabolic syndrome in Japanese.
Kato M; Takahashi Y; Inoue M; Tsugane S; Kadowaki T; Noda M;
Asia Pac J Clin Nutr; 2008; 17(2):223-8. PubMed ID: 18586640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
